RVP: נכסי החברה Retractable Tech

Retractable Technologies (RVP) generates revenue through the sale of VanishPoint safety blood collection systems and syringes designed to eliminate physician needlestick injuries. Production efficiency is sustained by the implementation of energy-saving molding technologies and wastewater treatment. This price chart reflects the dynamics of total assets, which currently stand at 154.51. This strategy minimizes toxic waste volume, simplifying polymer disposal and supporting ESG principles.

Total assets, calculated inversely via ROA, combine equity and liabilities to assess the business's resource potential. The current value of 154.51 in the total asset analysis (via ROA) reflects the management efficiency of production capacities and the engineering staff at Retractable Technologies (RVP), demonstrating a balance between investments in medical device safety and the company's final profitability.